Framingham, MA — At HUPO 2024, SCIEX, a global leader in life science analytical technologies, advances its high-resolution accurate mass spectrometry portfolio with the launch of the ZenoTOF 7600+ system accompanied by three new collaborations advancing proteomics capabilities. As the newest system to the ZenoTOF line, the ZenoTOF 7600+ system features the cutting-edge ZT Scan DIA strategy, leveraging the combination of […]
Shanghai – On the morning of October 21, 2024 PerkinElmer and Shandong University School of Public Health reached a cooperation agreement on the application of mass spectrometry technology in the field of public health and held an unveiling ceremony. This collaboration aims to jointly advance scientific research, talent cultivation, and technology application in the public […]
Robust, Unbiased and Affordable 4D-Proteomics™ for Highest-Specificity Protein IDs & Quant Enables High-Fidelity Large-Scale Plasma Proteomics Typical Sequence Coverage >10 Peptides/protein and >100k Peptides per Cell-Line Proteome Ushers in HiFi Proteomics with High Isoform Specificity Novel diagonal-PASEF ® methods for immunopeptidomics and PTM characterization Achieving one-hundred-dollar high-fidelity plasma proteomics with PreOmics ENRICH™ and robust timsTOF HT acquisition for deep, unbiased plasma proteomics at scale with 99% specificity […]
Elevating lab efficiency with enhanced automation, connectivity, and sustainability capabilities SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced the release of its next generation Agilent InfinityLab LC Series portfolio, which includes the 1290 Infinity III LC, 1260 Infinity III Prime LC, and 1260 Infinity III LC systems, all including the biocompatible versions. These […]
HUPO, Dresden, Germany – Evosep, a global leader in proteomics solutions, is proud to announce its relocation to new headquarters in Odense. This move will significantly enhance the company’s ability to advance the use of proteomics as a vital tool for the pharmaceutical and biotech industries. Building on recent strategic initiatives, the new facility will serve […]
On October 10, Shimadzu signed an agreement related to comprehensive collaboration with Waseda University, with the aim of promoting mutual collaboration, including research and development, and the fostering of human resources. Based on this collaborative agreement, both parties will work to develop new products and foster highly specialized human resources through collaborative research aiming at […]
Biognosys’ proprietary P2 Plasma Enrichment System enables plasma proteome profiling with unprecedented depth and throughput, both as contract research and in-house via licensing By offering the combination of NULISA™ affinity-based assays and TrueDiscovery® mass spectrometry-based plasma profiling with P2 Plasma Enrichment, Biognosys offers the industry’s most comprehensive solutions for plasma proteomics Spectronaut® workflows for high-performance computing environments, […]
Latest release offers an innovative characterization workflow for oligonucleotide therapeutics and expedites high-throughput peptide mapping data review. Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the latest release of Genedata Expressionist®18.5, a platform for streamlining and automating characterization and quality monitoring of biotherapeutics using mass spectrometry (MS). […]
Waters new LC-MS grade reagents, enzymes, and software simplify large molecule RNA analysis to accelerate and improve development of mRNA vaccines, personalized cancer therapies, and innovative drugs for genetic disorders. Novel digestion enzymes deliver complete RNA sequence coveragei for more confident characterization, while new LC-MS-grade reagents increase sensitivity and improve detection accuracy of RNA components.ii New waters_connect™ MAP Sequence […]
The collaboration leverages Nyctea’s unique expertise and its proprietary Nyctea® platform technology to improve the purification process for a drug compound that AstraZeneca is developing within its Research and Development program. Under the collaboration, Nyctea Technologies will apply its proprietary Nyctea® platform for improving purification of advanced therapy medicinal products (ATMPs). The Nyctea® platform stands […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
